Industry News

Dr Tom Davies and Dr Giulia Masetti, research scientists from Cultech Limited, present the findings of an exciting new study at the MicrobiotaMI 2018 scientific conference in Milan.

Infants and children who received probiotics to reduce the risk of acute respiratory tract infections, acute lower digestive tract infections or acute otitis media have a 29% lower relative risk [...]

This review assessed the efficacy of probiotics, prebiotics or synbiotics in the management of non-alcoholic fatty liver disease (NAFLD). A total of 1309 patients with NAFLD from 25 studies (11 [...]

Probiotics significantly reduced the risk of atopic sensitisation by 29% when administered prenatally to the pregnant mother and postnatally to infant (RR 0.71; 95% CI, 0.57 to 0.89) and the risk [...]

Probiotics showed improvement of the clinical symptoms and quality of life in allergic rhinitis patients. The results from the studies investigating the potential of probiotic supplementation in [...]

House dust mites are one of the most common triggers of allergic rhinitis and asthma. This review summarises the current evidence for the use of probiotics in the prevention and treatment of [...]

The age-related changes in the human gut microbiota, potential implications on immune and inflammatory health and targeted therapies for healthy aging are presented in this review.   Link: [...]

Human gut microbiota plays a key role in health and disease. Antibiotics, medications and specific food ingredients influence the composition and diversity of the gut microbiota. Targeting the [...]

Upper respiratory tract symptoms such as sneezing, coughing, sore throat, runny and blocked nose are common among athletes during heavy training and competition. This review focuses on the [...]

Recently, the MiBioGen consortium initiative was announced with aim to gain a better understanding of the gut microbiome role as a mediator between genetic predisposition and health or disease in [...]